CSL Limited (OTCMKTS:CSLLY – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $105.45 and last traded at $104.05, with a volume of 13905 shares. The stock had previously closed at $104.71.
CSL Trading Down 0.8 %
The company has a fifty day moving average price of $96.49 and a 200-day moving average price of $94.50.
About CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Articles
- Five stocks we like better than CSL
- What Are the U.K. Market Holidays? How to Invest and Trade
- Real Estate Stock Signals a Boom in Manufacturing Activity
- Using the MarketBeat Dividend Yield Calculator
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- What is Forex and How Does it Work?
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
